Allergy Vaccines
Total Trials
26
As Lead Sponsor
As Collaborator
0
Total Enrollment
4,551
NCT00104377
Induction of Immunogenicity With Different Doses of Grass MATA in Subjects Allergic to Grass and Rye Pollen
Phase: Phase 2
Role: Lead Sponsor
Start: Mar 31, 2005
Completion: Nov 30, 2005
NCT00104390
Assessment of Residual Allergenicity of Grass/Rye Pollen Allergoid Using Skin Prick Testing
Phase: Phase 1
Completion: Apr 30, 2005
NCT00107705
Assessment of Residual Allergenicity of Tree (Birch, Hazel, and Alder) Pollen Allergoid Using Skin Prick Testing
Start: Apr 30, 2005
Completion: May 31, 2005
NCT00109759
Evaluation of Safety and Tolerability of Tyrosine Adsorbed Ragweed Pollen Allergoid With MPL (Monophosphoryl Lipid A)
Start: May 31, 2005
Completion: Jun 30, 2005
NCT00110786
Investigation of Efficacy and Safety of Ragweed MATAMPL, Pollinex-R and Placebo in Patients With Ragweed Allergy
Completion: Dec 31, 2005
NCT00116285
Assessment of Residual Allergenicity of Ragweed Pollen Allergoid With Monophosphoryl Lipid A (MPL) Using Skin Prick Testing
Start: Jun 30, 2005
NCT00118612
Different Doses of Tyrosine Adsorbed Tree Pollen Allergoid With Monophosphoryl Lipid A (MPL) in Patients Sensitized to Tree Pollen
Start: Jul 7, 2005
Completion: Sep 15, 2005
NCT00113750
Induction of Immunogenicity With Different Doses of TreeMATA in Subjects Allergic to Tree Pollen
Start: Jul 31, 2005
NCT00118625
Assessment of the Contribution of Monophosphoryl Lipid A (MPL) to a Tree Pollen Allergy Vaccine
Completion: Sep 30, 2005
NCT00133146
Assessment of the Contribution of Monophosphoryl Lipid A (MPL) to a Grass Pollen Allergy Vaccine
Start: Sep 12, 2005
Completion: Nov 23, 2005
NCT00133159
Different Doses of Tyrosine Adsorbed Grass Pollen Allergoid With Monophosphoryl Lipid A (MPL) in Patients Sensitized to Grass Pollen
Completion: Nov 8, 2005
NCT00258635
Investigation of Safety+Efficacy of Different Doses of RagweedMATAMPL;Assessment of Residual Allergenicity Using Skin Prick Test
Start: Nov 30, 2005
Completion: Aug 7, 2006
NCT00241410
Safety, Immunological Effect and Efficacy of the Combined Application of MPL and Grass Pollen Allergen
Start: Dec 31, 2005
Completion: Jan 31, 2007
NCT00325338
Follow-up Investigation of Efficacy of Ragweed MATAMPL,and Placebo in Patients With Ragweed-induced Seasonal Allergic Rhinitis
Start: May 31, 2006
Completion: Jul 31, 2006
NCT00387478
Investigation of Efficacy and Safety of Tree MATAMPL,Tree MATA, and Placebo in Patients With Birch-Induced Seasonal Allergic Rhinitis
Start: Oct 31, 2006
Completion: Jul 31, 2007
NCT00414141
Efficacy and Safety/Tolerability of Grass MATA MPL
Phase: Phase 3
Start: Nov 30, 2006
Completion: Nov 30, 2007
NCT00423787
Efficacy and Safety/Tolerability of Ragweed MATA MPL
Start: Mar 31, 2007
Completion: Mar 31, 2008
NCT02557633
A Study of Tolerability and Safety of Two New Doses of Grass MATA MPL
Start: Aug 31, 2015
Completion: Oct 31, 2016
NCT02582073
Dose Selection Study of Efficacy and Safety of Different Doses of Grass MATA MPL and Grass MATA Using mEECs™
Start: Nov 7, 2015
Completion: Apr 28, 2017
NCT03931993
A Study of Tolerability and Safety of a New Cumulative Dose of Grass MATA MPL
Start: Jan 16, 2017
Completion: Apr 27, 2017
NCT04389034
Influence of Specific Immunotherapy With Pollinex Quattro (Tree-/Grass Pollen) on Allergen-specific Immunoglobulin E (IgE) Levels
Phase: N/A
Start: Apr 22, 2020
Completion: Oct 5, 2020
NCT04687059
An Exploratory Study of PQ Grass 27600 SU
Phase: Phase 2/3
Start: Oct 19, 2020
Completion: Oct 28, 2021
NCT05186025
Tyrosine Allergoid Paediatric and Adult Study
Start: Nov 6, 2020
Completion: Oct 31, 2026
NCT05455749
Effect of holoBLG on Cat Allergic Patients
Start: Oct 4, 2021
Completion: Mar 16, 2022
NCT05540717
Efficacy and Safety of PQ Grass in Subjects With Seasonal Allergic Rhinitis and/or Rhinoconjunctivitis Induced by Grass Pollen
Start: Oct 11, 2022
Completion: Nov 1, 2023
NCT05476497
Phase I Trial to Evaluate VLP Peanut in Healthy and Peanut Allergic Subjects
Start: Oct 17, 2022
Completion: Oct 31, 2025
Loading map...